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Abstract
Acute myocardial infarction is one of the important reasons of death and unhealthiness in the world. The present 
study was undertaken to investigate the changes in serum lipids and lipoproteins in patients with acute myocar-
dial infarction. This study was performed in the Biochemistry and Metabolic Disorder Research Center of Gor-
gan, Golestan province (South East of Caspian Sea), Iran in 2011.The levels of lipid profile were significantly 
changed in the acute myocardial infarction patients. acute myocardial infarction patients had significantly higher 
levels of total cholesterol, LDL-cholesterol, VLDL-cholesterol, TG, LDL-cholesterol /HDL-cholesterol, total cho-
lesterol /HDL-cholesterol, LDH, CPK and CPK-MB and lower  level of HDL-cholesterol, as compared to the con-
trol subjects. We found a significant association of lipid profiles with acute myocardial infarction. Changing of 
dietary and social activity habits of people in this area can help to prevent future atherogenic damaging in AMI 
patients. Changing of dietary and social activity habits of people in this area can help to prevent future athero-
genic damaging in AMI patients. Reduced serum HDL-cholesterol in our study subjects may be one of the effec-
tive reasonable lipid disorders in AMI patients 
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Introduction 
Acute myocardial infarction is one of the important 
reasons of death and unhealthiness in the world. Various 
risk factors for coronary heart disease have been reported, 
including age, gender, race and family history  and an 
another risk factors, like serum cholesterol, smoking, 
diabetes and high blood pressure can be changed [1]. 
Myocardial Infarction (MI) comes together as a results of 
environmental causes and personal susceptibilities [2-5]. 
In the United States and United Kingdom, nearly 650,000 
and 180000 patients get an acute myocardial infarction 
(AMI) every year, respectively [6]. According to WHO 
planned in the year 2005 that the coronary heart disease 
causes for 7.6 million deaths (13.2% of total deaths) 
whole world. Above 80% of these deaths took place in 
fewer developing countries [7]. In our country, Iran, rate 
of death because of cardiovascular disease comprised 
26.6% and 47.3% of deaths in the years 1987 and 1995, 
respectively [8]. Acute myocardial infarction accounts for 
a very many of deaths in Iran [9]. There are several 
assessments on the variations of serum lipid profiles 
following myocardial infarction. Many researchers have 
reported a decrease in total cholesterol [10-19], HDL-
cholesterol [18] and LDL-cholesterol [16-18] after acute 
myocardial infarction. In another studies showed that 
there is no modification in serum total cholesterol [20], 
HDL-cholesterol [16, 20] and triglycerides levels [13, 20-
23]. Various studies have shown that the total cholesterol 
to HDL cholesterol and of LDL cholesterol to HDL chol-
esterol ratios can be used as predictors of acute coronary 
occurrences [24-25]. The present study was undertaken to 
investigate the changes in serum lipids and lipoproteins in 
Patients  with   acute  myocardial   infarction   in   Gorgan 
(South East of Caspian Sea), Iran.
Materials and Methods
This study was performed in the Biochemistry and Meta-
bolic Disorder Research Center of Gorgan, Golestan 
province (South East of Caspian Sea), Iran in 2011. The 
study group included 35 subjects (12 females and 23 
males)  with acute myocardial infarction (with the mean 
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age of 11.44±57.22  years old) who were referred to the 
intensive Coronary Care Unit  in 5th Azar Hospital ( the 
only general teaching hospital in Gorgan), Gorgan Fac-
ulty of Medicine, Golestan University of Medical Sci-
ences. None of the patients had thyroid dysfunction, dia-
betes, hypertension and liver or kidney disease. All the 
included subjects provided an informed consent. We also 
chosen 35 healthy subjects (12 females and 23 males with 
the mean age of 55.80±13.15 years old) as our control 
group and matched them for age and gender. The exclu-
sion criterion was the coexistence of any other serious 
illness. A venous blood sample was collected from all the 
subjects after 12-hours overnight fast. The samples were 
centrifuged for 10 minutes at 3000 rpm.   Fasting levels of 
serum blood glucose, total cholesterol, High Density 
Lipoprotein (HDL) cholesterol, Low Density Lipoprotein 
cholesterol (LDL) Very Low Density Lipoprotein choles-
terol (VLDL), Triglycerides (TG), lactate dehydrogenase 
(LDH) and Creatine Phospho Kinase (CPK) and Creatine 
Phospho Kinase-MB (CPK-MB) levels were measured by 
enzymatic methods using spectrophotometer techniques 
(Model JENWAY 6105 UV / VIS) in the Biochemistry 
and Metabolic Disorder Research Center (Faculty of 
Medicine). Acute myocardial infarction was defined as 
prolonged chest pain and was diagnosed as acute myocar-
dial infarction on clinical examination, electrocardio-
graphic changes and laboratory basis. The results were 
reported as mean ± SD. The statistical analysis was done 
with SPSS- 11.5 version software. The results were 
evaluated by using student't' test to determine the signifi-
cance of biochemical parameters among two groups. Sta-
tistical significance was considered at P < 0.05. 
 
 
Results 
The clinical characteristics of acute myocardial infarction 
patients and control subjects have been shown in tables 1, 
2, 3, 4 and 5. A number of obvious differences between 
two subjects are found. Table 1 shows that acute myocar-
dial infarction patients had higher levels of total choles-
terol, LDL-cholesterol, VLDL-cholesterol, TG, LDL-
cholesterol /HDL-cholesterol, total cholesterol /HDL-
cholesterol, LDH, CPK and CPK-MB and lower  level of 
HDL-cholesterol, as compared to the control subjects. 
Notably, all above mentioned biochemical parameters 
(HDL-cholesterol was significantly lower) were signifi-
cantly higher in acute myocardial infarction patients than 
in control subjects (P< 0.05) (Table1).Table 2 shows 
comparison of biochemical parameters between males 
and females acute myocardial infarction patients. The 
data shown in Table 2 reveals that there was no signifi-
cant difference in all parameters in female and male pa-
tients. Table 3 shows comparison of biochemical parame-
ters between males and females control groups. There was 
no significant difference in all parameters in both genders. 
The data of Table 4 shows that female acute myocardial 
infarction patients had significantly higher levels of total 
cholesterol, LDL-cholesterol, VLDL-cholesterol, TG, 
LDL-cholesterol /HDL-cholesterol, total cholesterol 
/HDL-cholesterol LDH, CPK and CPK-MB and signifi-
cantly lower level of HDL-cholesterol, as compared to 
female control subjects (P< 0.05). The data of Table 5 
shows that male acute myocardial infarction patients had 
significantly higher levels of in table 4 mentioned bio-
chemical parameters when compared with male control 
subjects (P< 0.05). But this is not the same for total cho-
lesterol in male acute myocardial infarction patients when 
compared with male control subjects 
 
Table 1. Biochemical parameters in acute myocardial infarction patients and control groups 
 
 
Parameters 
 
Acute myocardial infarction patients 
(n=35) 
 
Control groups 
(n=35) 
 
 
P-value 
Age (year) 11.44±57.22 55.80±13.15 0.605 
Fasting blood sugar (mg/dl) ±15.81108.43 99.94±8.26 0.013 
Blood urea nitrogen (mg/dl) ±8.3420.60 18.97±3.75 0.332 
Creatinine (mg/dl) ±0.231.08 0.99±0.14 0.057 
Creatine phosphokinase (U/L) 2104.10±1744.73 123.63±27.17 0.001 
Creatine phosphokinase MB(U/L) ±135.52165.09 22.11±3.45 0.001 
Low density lipoprotein (mg/dl) ±22.67117.03 87.57±20.78 0.001 
High density lipoprotein (mg/dl) ±5.1840.62 61.57±11.59 0.001 
Very Low density lipoprotein (mg/dl) 33.73±3.46 24.73±6.34 0.001 
Total cholesterol(mg/dl) ±44.24201.86 181.37±15.32 0.001 
Triglycerides (mg/dl) 168.69±17.34 123.69±31.71 0.001 
Lactate dehydrogenises(U/L) ±786.341590.20 369.83±53.73 0.001 
LDL-cholesterol/HDL-cholesterol 2.95±0.80 1.41±0.46 0.001 
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Table 2: Comparison of biochemical parameters between males and females acute 
 myocardial infarctionPatients 
 
Parameters Females  (n=12) Males (n=23) P-value 
Age (year) 60.33±8.27 12.65±55.60 0.329 
Fasting blood sugar (mg/dl) 109.17±12.93 108.04±17.39 0.693 
Blood urea nitrogen (mg/dl) 20.58±4.85 20.60±9.79 0.423 
Creatinine (mg/dl) 1.10±0.26 1.06±0.22 0.845 
Creatine phosphokinase(U/L) 1843.80±566.43 2239.90±2118.46 0.394 
Creatine phosphokinase MB(U/L) 137.25±119.03 179.61±143.72 0.429 
Low density lipoprotein (mg/dl) 119.50±25.84 115.74±21.34 0.249 
High density lipoprotein (mg/dl) 42.50±5.77 39.65±4.68 0.178 
Very Low density lipoprotein (mg/dl) 34.33±3.81  33.42±3.32 0.566 
Total cholesterol(mg/dl) 217.17±57.20 193.87±34.57 0.169 
Triglycerides (mg/dl) 171.67±19.05 167.13±16.60 0.566 
Lactate dehydrogenises(U/L) 1474.20±766.0 2101.70±809.78 0.055 
LDL-cholesterol/HDL-cholesterol 2.91±0.98 2.97±0.71 0.841 
Total cholesterol/ HDL-cholesterol 5.30±2.02 4.96±1.11 0.682 
 
Table 3.  Comparison of biochemical parameters between males and females control subjects 
 
Parameters Females  (n=12) Males (n=23) P-value 
Age (year) 58.75±15.19 54.25±12.03 0.864 
Fasting blood sugar (mg/dl) 101.42±8.10 99.17±8.42 0.125 
Blood urea nitrogen (mg/dl) 17.91±4.39 19.52±3.34 0.786 
Creatinine (mg/dl) 0.98±0.12 0.99±0.15 0.590 
Creatine phosphokinase (U/L) 119.42±27.26 125.83±27.47 0.273 
Creatine phosphokinase MB (U/L) 21.08±2.60 22.65±3.76 0.213 
Low density lipoprotein (mg/dl) 88.41±8.08 87.13±25.18 0.782 
High density lipoprotein (mg/dl) 55.91±8.42 64.52±12.05 0.365 
Very Low density lipoprotein (mg/dl) 23.90±9.47 25.17±4.09 0.930 
Total cholesterol(mg/dl) 182.0±19.82 181.04±12.88 0.703 
Triglycerides (mg/dl) 119.50±47.35 125.87±20.46 0.930 
Lactate dehydrogenises (U/L) 375.67±51.44 366.78±55.76  
LDL-cholesterol/HDL-cholesterol 1.60±0.22 1.42±0.54 0.369 
Total cholesterol/ HDL-cholesterol 3.29±0.51 2.89±0.60 0.406 
 
Table 4. Comparison of biochemical parameters between females acute myocardial infarction patients and control subjects 
 
Parameters Females acute myocar-
dial infarction patients 
(n=12) 
Females control subjects 
(n=12) 
P-value 
Age (year) 60.33±8.27 58.75±15.19 0.703 
Fasting blood sugar (mg/dl) 109.17±12.93 101.42±8.10 0.065 
Blood urea nitrogen (mg/dl) 20.58±4.85 17.91±4.39 0.148 
Creatinine (mg/dl) 1.10±0.26 0.98±0.12 0.192 
Creatine phosphokinase(U/L) 1843.80±566.43 119.42±27.26 0.001 
Creatine phosphokinase MB(U/L) 137.25±119.03 21.08±2.60 0.001 
Low density lipoprotein (mg/dl) 119.50±25.84 88.41±8.08 0.003 
High density lipoprotein (mg/dl) 42.50±5.77 55.91±8.42 0.001 
Very Low density lipoprotein (mg/dl) 34.33±3.81 23.90±9.47 0.001 
Total cholesterol(mg/dl) 217.17±57.20 182.0±19.82 0.043 
Triglycerides (mg/dl) 171.67±19.05 119.50±47.35 0.012 
Lactate dehydrogenises(U/L) 1474.20±766.0 375.67±51.44 0.001 
LDL-cholesterol/HDL-cholesterol 2.91±0.98 1.60±0.22 0.001 
Total cholesterol/ HDL-cholesterol 5.30±2.02 3.29±0.51 0.004 
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Table 5. Comparison of biochemical parameters between males acute myocardial infarction patients and 
control subjects 
 
Parameters Males acute myocardial 
infarction patients  
(n=23) 
Males control subjects 
(n=23) 
P-value 
Age (year) 12.65±55.60 54.25±12.03 0.715 
Fasting blood sugar (mg/dl) 108.04±17.39 99.17±8.42 0.066 
Blood urea nitrogen (mg/dl) 20.60±9.79 19.52±3.34 0.652 
Creatinine (mg/dl) 1.06±0.22 0.99±0.15 0.117 
Creatine phosphokinase (U/L) 2239.90±2118.46 125.83±27.47 0.001 
Creatine phosphokinase MB (U/L) 179.61±143.72 22.65±3.76 0.001 
Low density lipoprotein (mg/dl) 115.74±21.34 87.13±25.18 0.001 
High density lipoprotein (mg/dl) 39.65±4.68 64.52±12.05 0.001 
Very Low density lipoprotein (mg/dl) 33.42±3.32 25.17±4.09 0.001 
Total cholesterol(mg/dl) 193.87±34.57 181.04±12.88 0.114 
Triglycerides (mg/dl) 167.13±16.60 125.87±20.46 0.001 
Lactate dehydrogenises (U/L) 1650.0±806.89 366.78±55.76 0.001 
LDL-cholesterol/HDL-cholesterol 2.97±0.71 1.42±0.54 0.001 
Total cholesterol/ HDL-cholesterol 4.96±1.11 2.89±0.60 0.001 
 
 
Discussion 
 
Coronary heart diseases are the most important factor of 
death [26]. There is an increasing prevalence of these dis-
eases in developing countries [7]. Study of Bitla et al [27] 
showed that Patients with MI showed no significant 
change in lipid profile when compared to healthy con-
trols. Ryder et al. [28] reported that there is no significant 
alteration in triglyceride levels. Study of Vetter et al. [29] 
showed that triglyceride levels diminished slowly from 
the second hour after myocardial infarction. Some studies 
showed that there are correlations between the occurrence 
of AMI and abnormality of lipid profiles [30]. Some other 
study showed that there was an increase in serum triglyc-
erides during AMI [31, 32]. Study of Salahuddin et al. 
revealed significantly high levels of triglycerides and low 
levels of HDL-cholesterol in AMI patients compared to 
control subjects [32]. In our present study, serum triglyc-
eride levels showed significant increase in AMI patients 
when compared with control subjects. According to the 
present study, this result was in agreement with our find-
ing. There is a different mechanism about elevation of 
triglycerides after MI.  It is reported that elevated triglyc-
eride levels may depend on genetic basis [33] and nutri-
tional habits [34]. Triglyceride levels may change because 
of inherited abnormality of very low density lipoprotein It 
may be happen because of increased flowing of fatty ac-
ids and impaired elimination of VLDL from the plasma 
[35].We found significant change in serum total choles-
terol levels after acute myocardial infarction. Our study is 
in agreement and in contrast to that by other researchers 
who found either an increase [36, 12] or a decrease [37-
39, 28 and 40] or normal cholesterol [30, 41] during the 
acute myocardial infarction. This shows that serum cho-
lesterol level reveal no differences between persons with 
and without AMI. Elevated serum cholesterol has de-
pended on elevated consumptions of fat [42] and genetic 
basis [33]. LDL carries the most of cholesterol in the 
plasma and increasing of LDL depend on increasing of 
total cholesterol level [43]. Reduction of HDLc concen-
tration in our findings is not in agreement with the other 
studies that shown either a increase [40] or no change 
[41] and in agreement with the other study [32]. Several 
studies have supported that the ratios of LDL-cholesterol 
/HDL-cholesterol and total cholesterol /HDL-cholesterol 
show the atherosclerotic injury of the wall of the vessels 
[44-46]. We found significant increase in ratios of LDL-
cholesterol /HDL-cholesterol and total cholesterol /HDL-
cholesterol levels after acute myocardial infarction. The 
latest studies in agreement with our studies. Study of 
Some studies have shown that there is a significant de-
crease in LDL-cholesterol following MI [47, 28]. Sand-
kamp et. al. (48) showed that LDL-Ch level increased and 
this is in agreement with our finding. LDL-Ch level may 
be increase as a result of reducing in refining or excessive 
production of LDL-Ch [49]. LDL cell surface receptors 
cleaned LDL-Ch from the circulation. These receptors 
may change as a result of coronary heart disease, thus 
uptake of LDL-Ch is decreased [50]. On the other hand, 
increasing of LDL possibly as a result of excessive pro-
duction of VLDL and /or decreasing of VLDL remnants 
(Low activity of LDL receptors)[51]. The results of our 
study shows significant increase in total cholesterol, 
LDL-cholesterol, VLDL-cholesterol, TG, LDL-
cholesterol /HDL-cholesterol and total cholesterol /HDL-
cholesterol after acute myocardial infarction. Thus, we 
found a significant association of lipid profiles with acute 
myocardial infarction. Changing of dietary and social ac-
tivity habits of people in this area can help to prevent fu-
ture atherogenic damaging in AMI patients. Reduced se-
Lipid profiles in acute myocardial infarction patients  
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rum HDL-cholesterol in our study subjects may be one of 
the effective reasonable lipid disorders in AMI patients.   
 
Acknowledgement 
 
The authors would like to thank the personnel at the Bio-
chemistry and Metabolic Research Center and cardiology 
center of Golestan University of Medical Sciences for 
providing for their cooperation and assistance in the han-
dling of experiments. 
 
References 
 
1. Camm AJ. Cardiovascular disease. In: Kumar P, Clark 
M. Clinical Medicine. 5th ed. London: Bath Press, 
2002: 766-783. 
2. Ahmed IA. Myocardial-infraction based on intelligent 
techniques. Am J Applied Sci 2010; 7: 349-351.  
3. Dehlaghi V, Najarian S, Shadpour MT. Effect of stent 
geometry on phase shift between pressure and flow 
waveforms in stented human coronary artery. Am J 
Applied Sci 2008; 5: 340-346.  
4. Jahromi AS, Shojaie M, Dana S, Madani A. Anti-
cardiolipin antibody in acute myocardial infarction. Am 
J Immunol 2010; 6: 11-14.  
5. Zimmerman FH, A. Cameron LD, Ng G. Myocardial 
infarction in young adults: Angiographic characteriza-
tion, risk factors and prognosis (coronary artery surgery 
study registry). J Am Coll Cardiol 1995; 26: 654-661.  
6. Braunwald E. Approach to the patient with cardiovas-
cular disease. In: Kasper DL, Braunwald E, Fauci AS, 
Hauser SL, Longo DL, Jameson JL. Harrison’s Princi-
ples of Internal Medicine; 16th ed. New York: 
McGraw-Hill, 2005; 1301-1494. 
7. World Health Organization. The World Health Report: 
reducing risks, promoting healthy life [Online]. 2002; 
Available from: URL: http://www.who.int/whr/2002/-
en. 
8. Sarrafzadegan N, Boshtam M, Malekafzali H, Bashar-
doost N, Sayedtabatabaei FA, Rafiei M, et al. Secular 
trends in cardiovascular mortality in Iran, with special 
reference to Isfahan. Acta Cardiol 1999; 54 (6): 327-
333. 
9. Azizi F, Hatami H, Janghorbani M. Epidemiology of 
Common Diseases in Iran. 2nd ed. Tehran Didavar 
Company, 2001; pp. 10-22. 
10. Biorch, G., Blomquist, G. and Sievers, J. Cholesterol 
values in patients with myocardial infarction and nor-
mal control group. Acta Med Scand 1957; 156: 493-
497. 
11. Bjorntrop P, Malmcrone R. Serum cholesterol in pa-
tient with myocardial infarction in younger ages. Acta 
Med Scand 1960; 168: 151-155. 
12. Dodds, C. and Mills, G.L. Influence of myocardial in-
farction on plasma lipoprotein concentration. Lancet. 
1959; 1160 -1163. 
13. Tibblin G, Cramer K. Serum lipids during the course of 
acute myocardial infarction and one year afterwards 
Acta Med Scand 1963; 174, 451-455. 
14. Fyfe T, Baxter RH, Cochran KM, Booth EM. Plasma 
lipid changes’after myocardial infarction. Lancet. 1971; 
997-1001. 
15. Kirkeby K. Disturbances in serum lipids and in their 
fatty’ acid composition following acute myocardial in-
farction. Acta Med Scand 1972; 192: 523-528. 
16. Avogaro A, Bittilin Bon G, Cazzalato C, Quinci GB, 
Sanson A, Sparla H, Zagatti GC. Variations in apolipo-
proteins B and A during the course of myocardial in-
farction. Eur. J. Clin. Invest. 1978; 8; 121-129. 
17. Ballantyne FC, Melville DA, Mc Kenna JP, Morrison 
BA, Ballantyne D. Response of plasma lipoproteins 
and acute phase proteins to myocardial infarction. Clin 
Chim Acta 1979; 99: 85-92. 
18. Ryder REJ, Hayes TM, Mulligan IP, Kingswood JC, 
Williams S, Owens DR.  How soon after myocardial 
infarction should plasma lipid values be assessed? Br 
Med J 1984; 289: 1651-1653.. 
19. Jackson, R., Scragg, R., Marshall, R, White, O’Brien, 
K. and Small, C. Changes is serum lipid concentrations 
during first 24, hours after myocardial infarction. Br. 
Med. J. 1987; 294, 1588-1589. 
20. Heldenburg, D., Rubenstein, A., Levtov, 0., Berns, L., 
Werbin, B. and Tamir, L. Serum lipids and lipoprotein 
concentrations during the acute phase of myocardial in-
farction. Atherosclerosis. 1980; 35,433-437. 
21. Fredrickson, D.S. The role of lipids in acute myocardial 
infarction. Circulation. 1969; 39, Suppl. IV-99-IV-III. 
22. Swedarsen, M., Vythilingum, S., Jialal, I. and Nadar, 
R. Plasma lipids can be reliably assessed within 24 
hours after acute myocardial infarction. Postgrad. Med. 
J. 1988; 64, 352-356. 
23. Castelli WP. Epidemiology of coronary heart disease: 
the Framingham Study. Am J Med 1984; 27: 4–12. 
24. Linn S, Fulwood R, Carroll M, et al. Serum total cho-
lesterol: HDL cholesterol ratios in US white and black 
adults by selected demographic and socioeconomic 
variables (HANES II). Am J Public Health 1991; 81: 
1038-1043. 
25. Jialal I, Devaraj S. Low density lipoprotein oxidation, 
antioxidants and atherosclerosis. Clin Chem. 1996; 42: 
498-506. 
26. Bitla AR, Pallavi M, Vanaja V, Suchitra MM, Reddy 
Seshadri V,  Prabhakar Reddy E, Srinivasa Rao 
P.V.L.N. Acute Myocardial Infarction in a Southeast 
Indian Population: Comparison of Traditional and 
Novel Cardiovascular Risk Factors Research Journal of 
Medicine and Medical Sciences. 2009; 4(2): 202-206. 
27. Ryder REJ, Hayes TM, Mulligan IP, Kingswood JC, 
Williams S, Owens DR. How soon after myocardial in-
farction should plasma lipid values be assessed? Br 
Med J 1984; 289; 1651-1653. 
28. Vetter NJ, Adams W, Strange RC, Oliver MF.  Initial 
metabolic and hormonal response to acute myocardial 
infarction. Lancet 1974; 284-289. 
Shirafkan/ Marjani/Ramazani 
 
Biomedical Research 2012 Volume 23 Issue 1 
29. Berlin R, Oldfelt CO, Vikrot O. Acute myocardial in-
fraction and plasma phospholipids levels. Acta Med. 
Scand. 1969; 185, 439-442. 
30. Pocock SJ, Shaper AG, Philips AN, Walker M, White-
head TP. High density lipoprotein cholesterol is not a 
major risk factor for ischemic heart disease. British 
Medical Journal. 1986; 292: 515-519. 
31. Salahuddin, Karira KA, Shah SMA, et al. Serum ho-
mocysteine in patients with acute myocardial infarc-
tion.  Pakistan J Cardiol. 2000; 11: 93-99.. 
32. Goldstein JL, Hazzard WR, Schrott HG : Hyperlipide-
mia in coronary heart disease. J Clin Invest. 1973; 52: 
1533-1543. 
33. Watts GF, Jackson P, Mandalia S. Nutrient intake and 
progression of coronary artery disease. Am J Cardiol. 
1994; 73: 328-332. 
34. Fredrickson DS. The role of lipids in acute myocardial 
infarction. Circulation. 1969; 39,Suppl. IV-99-IV-III 
35. Dyerberg J, Bang, H.O. and Neilsen, J.A. Plasma lipids 
and lipoproteins in patients with myocardial infarction 
and in a control material. Acta Med. Scand. 1970; 187, 
353-359. 
36. Bjorntrop P, Malmcrone R. Serum cholesterol in pa-
tient with myocardial infarction in younger ages. Acta. 
Med. Scand. 1960; 168, 151-155. 
37. Tibblin G, Cramer K. Serum lipids during the course of 
acute myocardial infarction and one year afterwards 
Acta Med. Scand. 1963; 174, 451-455. 
38. Kirkeby K.  Disturbances in serum lipids and in their 
fatty’ acid composition following acute myocardial in-
farction. Acta Med Scand 1972;192, 523-528. 
39. Jackson R, Scragg R, Marshall R, White O’Brien K, 
Small C. Changes in serum lipid concentrations during 
first 24, hours after myocardial infarction. Br. Med. J. 
1987; 294, 1588-1589. 
40. Heldenburg D, Rubenstein A, Levtov 0, Berns L, Wer-
bin B, Tamir L. Serum lipids and lipoprotein concentra-
tions during the acute phase of myocardial infarction. 
Atherosclerosis.1980; 35: 433-437. 
41. Garcia RM, Sorlie P, Costas R. Relationship of dietary 
intake to subsequent coronary heart disease incidence. 
American Journal of Clinical Nutrition 1980; 33:1818. 
42. Hargreaves AD, Logan RL and Thomson M: Total cho-
lesterol, LDL-Ch and HDL-Ch and coronary heart dis-
ease BMJ 1991; 303:678. 
43. Natio HK. The association of serumlipids, lipoproteins 
and apolipoproteins with coronary artery disease as-
sessed by coronary arteriography. Ann. N.Y. Acad. Sci. 
1985; 454, 230-238. 
44. Zampogna A, Luria MH, Mancibens SJ, Luria MA.  
Relationship between lipids and occlusive coronary 
disease. Arch. Intern Med 1980; 140, 1067-1069. 
45. Luria MH, Erel J, Sapoznikov D, Gotsman MS. Cardi-
ovascular risk factor clustering and ratio of total choles-
terol to high-density lipoprotein cholesterol in angio-
graphically documented coronary artery disease. Am. J. 
Cardiol. 1991; 67, 31-36. 
46. Ballantyne FC, Melville DA, Mc Kenna JP, Morrison 
BA, Ballantyne D. Response of plasma lipoproteins 
and acute phase proteins to myocardial infarction. Clin. 
Chim Acta 1979; 99, 85-92. 
47. Sandkamp M, Funke H and Schulte H : Lipoprotein (a) 
is an independent risk factor for myocardial infarction. 
Clin Chem 1990; 36: 20-23. 
48. Grundy SM, Vega GL, Kesaniemi YA. Abnormalities 
in metabolism of LDL associated with coronary heart 
disease. Acta Medica Scand 1985; 701: 23-37. 
49. Ball M and Mann JJ: Apoproteins: predictors of coro-
nary heart disease? Br Med J 1986; 27: 769- 770. 
50. Kromhout D: Body weight, diet and serum cholesterol 
in middle aged men during 10 years follow up. Am J 
Clin Nutr. 1983; 38: 591-598. 
 
Correspondence to: 
 
Abdoljalal Marjani 
Gorgan Faculty of Medicine 
Department of Biochemistry and Biophysics 
Gorgan Faculty of Medicine 
Golestan University of Medical Sciences 
Gorgan, Golestan Province, .Iran.  
 
 
